NLRP3 and chronic obstructive pulmonary disease: Therefore, it could be speculated that NLRP3 inflammasome is activated in COPD patients, and after successful lung transplantation without significant acute and chronic rejection, its activation is suppressed by finely tuned immune responses that are involved in the regulation of tissue homeostasis and host protection.